» Articles » PMID: 37100932

Substance Abuse and Neurodegenerative Diseases: Focus on Ferroptosis

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2023 Apr 26
PMID 37100932
Authors
Affiliations
Soon will be listed here.
Abstract

Psychostimulants and alcohol are widely abused substances with the adverse effects on global public health. Substance abuse seriously harms people's health and causes various diseases, especially neurodegenerative diseases. Neurodegenerative diseases include Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). The pathogenesis of neurodegenerative diseases is complex and diverse, usually involving oxidative stress, mitochondrial dysfunction, metal homeostasis disorder, and neuro-inflammation. The precise molecular mechanisms underlying neurodegeneration remain unclear, which is a major obstacle to therapeutic approaches. Therefore, it is urgent to improve the understanding of the molecular mechanisms of neurodegenerative processes and to identify the therapeutic targets for treatment and prevention. Ferroptosis is a regulatory cell necrosis caused by iron ion catalysis and lipid peroxidation induced by reactive oxygen species (ROS), which is thought to be associated with nervous system diseases, particularly neurodegenerative diseases. This review overviewed the ferroptosis process and explored the relationship of ferroptosis with substance abuse and neurodegenerative diseases, which provides a new way to study the molecular mechanisms of neurodegenerative diseases induced by alcohol, cocaine, and methamphetamine (MA), and also provides the potential therapeutic targets for substance abuse-induced neurodegenerative diseases.

Citing Articles

Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases.

Xu M, Li T, Liu X, Islam B, Xiang Y, Zou X Neurochem Res. 2024; 50(1):61.

PMID: 39673588 DOI: 10.1007/s11064-024-04311-9.


Examination of optical coherence tomography findings in patients with pregabalin use disorder.

Kilic O, Bayram Z, Kiyat P, Karti O, Aral A, Munis N PeerJ. 2024; 12:e18395.

PMID: 39544426 PMC: 11562773. DOI: 10.7717/peerj.18395.


Mechanisms and treatments of methamphetamine and HIV-1 co-induced neurotoxicity: a systematic review.

Miao L, Wang H, Li Y, Huang J, Wang C, Teng H Front Immunol. 2024; 15:1423263.

PMID: 39224601 PMC: 11366655. DOI: 10.3389/fimmu.2024.1423263.


Dopamine Pharmacodynamics: New Insights.

Lauretani F, Giallauria F, Testa C, Zinni C, Lorenzi B, Zucchini I Int J Mol Sci. 2024; 25(10).

PMID: 38791331 PMC: 11121567. DOI: 10.3390/ijms25105293.


Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis.

Mogavero M, Salemi M, Lanza G, Rinaldi A, Marchese G, Ravo M iScience. 2024; 27(4):109568.

PMID: 38617564 PMC: 11015462. DOI: 10.1016/j.isci.2024.109568.


References
1.
Aaseth J, Skalny A, Roos P, Alexander J, Aschner M, Tinkov A . Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease. Int J Mol Sci. 2021; 22(17). PMC: 8431716. DOI: 10.3390/ijms22179461. View

2.
Adisetiyo V, McGill C, DeVries W, Jensen J, Hanlon C, Helpern J . Elevated Brain Iron in Cocaine Use Disorder as Indexed by Magnetic Field Correlation Imaging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 4(6):579-588. DOI: 10.1016/j.bpsc.2018.11.006. View

3.
Aharonovich E, Nunes E, Hasin D . Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 2003; 71(2):207-11. PMC: 5804498. DOI: 10.1016/s0376-8716(03)00092-9. View

4.
Argyriou A, Karanasios P, Makridou A, Vlachou M, Giannakopoulou F, Makris N . Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis. Neurodegener Dis. 2010; 8(3):146-8. DOI: 10.1159/000318084. View

5.
Ayton S, Wang Y, Diouf I, Schneider J, Brockman J, Morris M . Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry. 2019; 25(11):2932-2941. PMC: 6698435. DOI: 10.1038/s41380-019-0375-7. View